Targeting targeted agents: open issues for clinical trial design
about
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trialsProof of concept to clinical confirmation: evolving clinical trial designs for targeted agents.Clinical trial design for testing the stem cell model for the prevention and treatment of cancer.PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer.Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.Early oncology clinical trial design in the era of molecular-targeted agents.Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors.Emerging pathways and future targets for the molecular therapy of pancreatic cancer.Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research.The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
P2860
Q33933669-0673D28A-2EA9-4637-B541-BF955A10A8ACQ36021866-F4B04512-AF84-4235-9641-2BAE302FAD1FQ37132809-B64F75D4-C238-4DF7-AF79-473E90F5AB38Q37655023-1814E609-2200-45E7-AE77-D38FB95A247DQ37731264-D539DAE4-4336-4EC3-B056-0A04A319DCAEQ37783623-BAE9D72A-EFF0-46A0-A6DF-CAABAEB50F29Q37821374-1806A9DE-A9F5-42E4-BDA9-19BD3FB0471EQ37912219-A5817D73-6B52-44B9-8D32-7315ADF30DE0Q41107504-956D7A40-9FDD-4D8B-B238-12F8ED55D477Q47161072-CA6B6A31-980D-4BDF-9E0D-D4C8C35879A2
P2860
Targeting targeted agents: open issues for clinical trial design
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting targeted agents: open issues for clinical trial design
@en
Targeting targeted agents: open issues for clinical trial design.
@nl
type
label
Targeting targeted agents: open issues for clinical trial design
@en
Targeting targeted agents: open issues for clinical trial design.
@nl
prefLabel
Targeting targeted agents: open issues for clinical trial design
@en
Targeting targeted agents: open issues for clinical trial design.
@nl
P2093
P2860
P50
P356
P1476
Targeting targeted agents: open issues for clinical trial design
@en
P2093
Federica Cuppone
Francesco Cognetti
Michele Milella
Paolo Carlini
P2860
P2888
P356
10.1186/1756-9966-28-66
P5008
P577
2009-05-22T00:00:00Z
P5875
P6179
1013133632